Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool

Allergy and Asthma Proceedings

Volumn 31, Issue 5, 2010, Pages 428-434

  Breitbart, Seth Ilias ^a   Bielory, Leonard ^b  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^b Center for Environmental Prediction   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; DIPHENHYDRAMINE; FOLIC ACID; GLIMEPIRIDE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN; LOSARTAN; MELOXICAM; METFORMIN; MULTIVITAMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; OXYBUTYNIN; POTASSIUM HYDROCHLOROTHIAZIDE; SIMVASTATIN; TAMSULOSIN; UNCLASSIFIED DRUG;

ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EOSINOPHILIA; HUMAN; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; PROTEIN ELECTROPHORESIS; SYMPTOMATOLOGY;

AGED; ANGIOEDEMA; AUTOANTIBODIES; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1Q; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 77958087120     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3361     Document Type: Article

References (50)

1. Leeyaphan C, Kulthanan K, Jongjarearnprasert K, and Dhana N. Drug-induced angioedema without urticaria: Prevalence and clinical features. J Eur Acad Dermatol Venereol 24:685-691, 2009.
2. Haymore BR, Yoon J, Mikita CP, et al. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: A meta-analysis. Ann Allergy Asthma Immunol 101:495-499, 2008.
3. Wong DT, and Gadsden JC. Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: A case report. Can J Anaesth 50:900-903, 2003.
4. Ciaccia D, Brazer SR, and Baker ME. Acquired C1 esterase inhibitor deficiency causing intestinal angioedema: CT appearance. AJR Am J Roentgenol 161:1215-1216, 1993.
5. Ferstl FJ, Jacob R, Ferstl B, and Obert R. Recurrent colicky abdominal pain. Isolated angioedema of the small intestine in acquired C1 inhibitor deficiency (type 1). Radiologe 43:997-999, 2003.
6. Cicardi M, Zingale LC, Pappalardo E, et al. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 82:274-281, 2003.
7. Dobson G, Edgar D, and Trinder J. Angioedema of the tongue due to acquired C1 esterase inhibitor deficiency. Anaesth Intensive Care 31:99-102, 2003.
8. Postlethwaite KR, and Parry DH. Acquired angioedema. Br J Oral Maxillofac Surg 26:499-502, 1988.
9. Mathur R, Toghill PJ, and Johnston ID. Acquired C1 inhibitor deficiency with lymphoma causing recurrent angioedema. Postgrad Med J 69:646-648, 1993.
10. Healy C, Abuzakouk M, Feighery C, and Flint S. Acquired angioedema in non-Hodgkin's lymphoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:e29-e32, 2007.
11. Banerji A, and Sheffer AL. The spectrum of chronic angioedema. Allergy Asthma Proc 30:11-16, 2009.
12. Bain BJ, Catovsky D, and Ewan PW. Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes. Cancer 72:3318-3322, 1993.
13. Cugno M, Castelli R, and Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev 8:156-159, 2008.
14. Heymann WR. Acquired angioedema. J Am Acad Dermatol 36:611-615, 1997.
15. Lin JH, Casillas AM, and Sattar S. C1-esterase inhibitor autoantibodies in a patient with acute tongue swelling. Allergy Asthma Proc 28:93-96, 2007.
16. D'Incan M, Tridon A, Ponard D, et al. Acquired angioedema with C1 inhibitor deficiency: Is the distinction between type I and type II still relevant? Dermatology 199:227-230, 1999.
17. Chevailler A, Arlaud G, Ponard D, et al. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol 97:998-1008, 1996.
18. Fremeaux-Bacchi V, Guinnepain MT, Cacoub P, et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med 113:194-199, 2002.
19. Zingale LC, Castelli R, Zanichelli A, and Cicardi M. Acquired deficiency of the inhibitor of the first complement component: Presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 26:669-690, 2006.
20. Silverman BA, Ku M, Kapur P, and Schneider AT. Monoclonal gammopathy in association with allergic disorders of the skin and respiratory tract. Allergy Asthma Proc 27:130-139, 2006.
21. Sanchez-Cano D, Callejas-Rubio JL, Lara-Jimenez MA, et al. Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndrome. Lupus 17:228-229, 2008.
22. Hissaria P, Lim SW, Hui CH, et al. Angioedema, lymphoproliferative disorder and angiotensin-converting enzyme inhibitors: Masking of diagnosis by corticosteroids. Intern Med J 37:650-653, 2007.
23. Nettis E, Colanardi MC, Loria MP, and Vacca A. Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: A case report and review of the literature. Eur J Clin Invest 35:781-784, 2005.
24. Bibi-Triki T, Eclache V, Frilay Y, et al. Acquired C1 inhibitor deficiency associated with lymphoproliferative disorders: Four cases. Rev Med Interne 25:667-672, 2004.
25. Reche M, Caballero T, Lopez-Trascasa M, et al. Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: Case report. AIDS 16:1561, 2002.
26. van Spronsen DJ, Hoorntje SJ, Hannema AJ, and Hack CE. Acquired angio-oedema caused by IgA paraprotein. Neth J Med 52:22-25, 1998.
27. Nagy L, Hannema A, and Swaak A. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, secondary antiphospholipid syndrome and IgM monoclonal paraproteinaemia. Clin Rheumatol 18:56-58, 1999.
28. Boyar A, Zuraw BL, and Beall G. Immunoadsorption in acquired angioedema: A therapeutic misadventure. Clin Immunol Immunopathol 66:181-183, 1993.
29. Zuraw BL, and Altman LC. Acute consumption of C1 inhibitor in a patient with acquired C1-inhibitor deficiency syndrome. J Allergy Clin Immunol 88:908-918, 1991.
30. Kleinhans D, Schach A, Ruther U, and Jipp P. Immunocytoma with acquired C1-esterase inhibitor deficiency and recurrent angioneurotic edema. Dtsch Med Wochenschr 111:742-744, 1986.
31. Sheffer AL, Austen KF, Rosen FS, and Fearon DT. Acquired deficiency of the inhibitor of the first component of complement: Report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol 75:640-646, 1985.
32. Guilarte M, Luengo O, Nogueiras C, et al. Acquired angioedema associated with hereditary angioedema due to C1 inhibitor deficiency. J Investig Allergol Clin Immunol 18:126-130, 2008.
33. Szeplaki G, Varga L, Szepvolgyi A, et al. Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency. Int Arch Allergy Immunol 146:164-168, 2008.
34. Sugisaki K, Itoh K, and Tamaru J. Acquired C1-esterase inhibitor deficiency and positive lupus anticoagulant accompanied by splenic marginal zone B-cell lymphoma. Clin Exp Rheumatol 25:627-629, 2007.
35. McLean-Tooke A, Stroud C, Sampson A, and Spickett G. Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency. J Clin Pathol 60:565-566, 2007.
36. Szeplaki G, Varga L, Osvath L, et al. Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: Effective treatment and follow-up for four years. Thromb Haemost 95:898-899, 2006.
37. Kumar MA, and Gupta C. Acquired angioedema secondary to hormone replacement therapy. Indian J Med Sci 59:451-454, 2005.
38. Phanish MK, Owen A, and Parry DH. Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema. J Clin Pathol 55:789-790, 2002.
39. Higa S, Hirata H, Minami S, et al. Autoimmune acquired form of angioedema that responded to danazol therapy. Intern Med 41:398-402, 2002.
40. Kleiner GI, Giclas P, Stadtmauer G, and Cunningham-Rundles C. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor. Ann Allergy Asthma Immunol 86:461-464, 2001.
41. Markovic SN, Inwards DJ, and Phyliky RP. Acquired C1 Esterase Inhibitor Deficiency. Ann Intern Med 133:839, 2000.
42. Nashan D, Sunderkotter C, Hamm H, et al. Life threatening angioedema caused by acquired C1 inhibitor deficiency associated with paraproteinemia and livedo racemosa. Hautarzt 46:339-342, 1995.
43. Bishop PC, Wisnieski JJ, and Christensen J. Recurrent angioedema and urticaria. West J Med 159:605-608, 1993.
44. Wasserfallen JB, Spaeth P, Guillou L, and Pecoud AR. Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma: A probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover. J Allergy Clin Immunol 95:124-131, 1995.
45. Nakamura S, Yoshinari M, Saku Y, et al. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system. Ann Rheum Dis 50:713-716, 1991.
46. Beretta KR, Spath PJ, Pedrazzini A, et al. Angioedema due to acquired complement-C1-inhibitor deficiency in a female patient with non-Hodgkin lymphoma and autoimmune hemolytic anemia. Schweiz Med Wochenschr 121:943-947, 1991.
47. Nilsen A, and Matre R. Acquired angioedema and hypocompleentemia in a patient with myelofibrosis. Effect of danazol treatment. Acta Med Scand 207:123-125, 1980.
48. Bowen T, Cicardi M, Bork K, et al. Hereditary angiodema: A current state-of-the-art review. In VII: Canadian-Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 100:S30-S40, 2008.
49. Agostoni A, Aygoren-Pursun E, Binkley EK, et al. Hereditary and acquired angioedema: Problems and progress. In Proceedings of the Third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-S131, 2004.
50. Schreiber AD, Zweiman B, Atkins P, et al. Acquired angioedema with lymphoproliferative disorder: Association of C1 inhibitor deficiency with cellular abnormality. Blood 48:567-580, 1976.